Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,400.00    -100.00 (-1.83%)
Bid:
5,300.00
Ask:
5,400.00
Spread: 100.00 (1.887%)
Market Cap: £136.50m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Trading Update

8 Mar 2023 07:00

RNS Number : 2183S
Camellia PLC
08 March 2023
 

8 March 2023

Camellia Plc

(the "Company" or the "Group")

 

Trading update

 

Further to the trading announcement on 7 December there has been a significant improvement to our expectations for underlying profit before tax for the Group for 2022.

 

Negotiations on pay in Bangladesh have now concluded resulting in a government mandated payment of Tk11,000 per permanent worker (payable during 2023) and a pay increase of 41.7% effective from the beginning of August 2022. This is a significantly improved outcome than anticipated and will be reflected in our 2022 results.

 

In addition, trading in our agriculture division in the final quarter of the year has been ahead of our expectations due to:

· Higher net sales prices achieved for India, Bangladesh and Kenya teas

· Better net sales prices for avocados

· Improved net sales prices achieved for both soya and maize

· Tighter control of production and overhead costs across the division

· Offset in part by lower net sales prices for macadamia and Malawi teas

 

We also further reduced our head office overhead costs.

 

Revenue for continuing operations* for 2022 is now expected to be approximately £294 million. As a consequence of the factors set out above, excluding any financial results for BF&M for 2022, the Company now believes that the adjusted profit before tax for continuing operations** for the Group for 2022 will be approximately 10% below the reported adjusted profit before tax for continuing operations (including BF&M share of results for that year) for 2021 which was £8.8 million. This compares very favourably to the Company's previous guidance given on 7 December 2022.

 

BF&M is expected to announce its results in April 2023 and until that time, as a consequence of the impact of the volatility of equity and bond markets on BF&M's results, it is not possible for Camellia to forecast the likely full year outcome for BF&M with any certainty.

 

 

* continuing operations are all operations except for ACS&T which was sold at the end of 2022

** adjusted profit before tax for continuing operations seeks to present an indication of performance for continuing operations which is not impacted by exceptional items or items considered non-operational in nature and for example it excludes impairment charges, gains/losses on disposal of assets and restructuring costs.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGGFMNMGFZZ
Date   Source Headline
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20258:29 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTrading Update
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSDisposal
5th Dec 20247:00 amRNSDisposal
11th Nov 20248:06 amRNSSale of Bangladesh associate companies
31st Oct 202411:37 amRNSDisposal
25th Oct 202412:51 pmRNSHolding(s) in Company
17th Oct 20247:00 amRNSTrading Statement
6th Sep 202411:44 amRNSInterim Report 2024
6th Sep 20247:00 amRNSHalf-year Report
1st Jul 20247:00 amRNSDirector Changes
28th Jun 20241:00 pmRNSUpdate on BF&M Transaction
7th Jun 202411:14 amRNSResult of AGM
6th Jun 20247:00 amRNSTrading Update
1st May 202412:30 pmRNSAnnual Report & Notice of Annual General Meeting
29th Apr 20247:00 amRNSFinal Results
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.